Doença renal crônica secundária ao diabetes e hipertensão: uma breve revisão de literatura
Revista ft · 17.05.2026 · 30 (158) · 01-18
DOI: 10.69849/6s1ekf63 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 17.05.2026. Verfasst von Ana Damiani Cabrini Neta und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION Chronic Kidney Disease (CKD) is characterized by the progressive and irreversible loss of kidney function, impairing the kidneys’ ability to filter metabolic substances and maintain the body’s homeostasis. It is a condition with slow progression and often asymptomatic in its early stages, which contributes to delayed diagnosis and an increased risk of clinical complications associated with the disease. In recent decades, CKD has emerged as an important global public health problem, showing a significant increase in its prevalence. Among the main risk factors for the development of chronic kidney disease are diabetes mellitus (DM) and systemic arterial hypertension (SAH). Both diseases cause structural and functional alterations in the kidneys, leading to progressive damage to the glomeruli and a reduction in the glomerular filtration rate. Furthermore, the concomitant presence of diabetes and hypertension significantly increases the risk of developing chronic kidney disease. Studies indicate that these two conditions are present in approximately 63% of CKD cases, demonstrating the strong relationship between these pathologies and renal impairment. OBJECTIVES. The general objective of this research is to analyze, through a review of the scientific literature, the relationship between diabetes mellitus and systemic arterial hypertension in the development and progression of chronic kidney disease, highlighting epidemiological, pathophysiological, diagnostic aspects, and strategies for prevention and clinical management. The specific objectives are: to describe the pathophysiology of chronic kidney disease associated with diabetes mellitus and systemic arterial hypertension; to analyze the prevalence and risk factors related to the development of chronic kidney disease in diabetic and hypertensive patients; to identify the main diagnostic methods used for early detection of chronic kidney disease in these patients, including the evaluation of the glomerular filtration rate and laboratory markers; to discuss the clinical complications and progression of chronic kidney disease associated with both conditions; and to present prevention and clinical management strategies aimed at controlling diabetes and hypertension in order to reduce the progression of chronic kidney disease. JUSTIFICATION. Chronic Kidney Disease (CKD) currently represents one of the main challenges for global public health due to its progressive nature, its significant impact on patients’ quality of life, and the high costs associated with treatment in advanced stages, such as dialysis and kidney transplantation. It is estimated that CKD affects approximately 10% of the world’s population, being considered a silent disease because many patients remain asymptomatic in the early stages, which makes early diagnosis difficult and favors disease progression. Given this scenario, expanding scientific knowledge about the relationship between diabetes mellitus, systemic arterial hypertension, and the development of chronic kidney disease is essential. In this sense, conducting a literature review allows the gathering and analysis of available evidence in the scientific literature, contributing to a better understanding of the mechanisms involved in disease progression, as well as identifying effective strategies for prevention, diagnosis, and clinical management. Therefore, this study is justified by the epidemiological relevance of chronic kidney disease and the need to strengthen scientific knowledge that supports actions for the prevention and control of these important health conditions. MATERIALS AND METHODS. The present study will be conducted through an integrative literature review, with a qualitative approach and a descriptive-exploratory design, aiming to gather and analyze scientific evidence regarding the relationship between diabetes mellitus, systemic arterial hypertension, and the development of chronic kidney disease. The integrative review allows the synthesis of results from different studies, contributing to a broader understanding of the investigated phenomenon. The bibliographic search will be carried out in widely recognized scientific databases in the health field, including Latin American and Caribbean Health Sciences Literature (LILACS), Medical Literature Analysis and Retrieval System Online (MEDLINE), Scientific Electronic Library Online (SciELO), the U.S. National Library of Medicine (PubMed), Google Scholar, and the Virtual Health Library (VHL), as these databases contain a large volume of relevant publications in the medical and biomedical fields. RESULTS/DISCUSSION. The analysis of the selected studies showed that chronic kidney disease (CKD) is strongly associated with chronic non-communicable diseases, particularly diabetes mellitus (DM) and systemic arterial hypertension (SAH). The findings reported in the literature demonstrate that these two conditions represent the main etiological factors related to the progressive impairment of renal function, reinforcing the hypotheses proposed in this research. Epidemiological studies indicate that the global prevalence of chronic kidney disease is approximately 9% to 11% of the adult population, highlighting the magnitude of this public health problem. Furthermore, research shows that cardiometabolic factors, especially hypertension and diabetes, are significantly associated with the development of chronic kidney disease and with increased cardiovascular risk in these patients. Among individuals with diabetes mellitus, several studies demonstrate a significant prevalence of renal impairment. In an investigation involving diabetic patients, approximately 26.5% presented chronic kidney disease, with hypertension, longer duration of diabetes, and family history of kidney disease identified as associated factors. Similarly, studies conducted with patients with systemic arterial hypertension show that this condition also has a significant influence on the deterioration of renal function. Research indicates that the prevalence of chronic kidney disease among hypertensive individuals may vary between 15% and 29%, values higher than those observed in the general population. FINAL CONSIDERATIONS. Chronic kidney disease (CKD) associated with diabetes mellitus and systemic arterial hypertension represents an important public health problem due to its high prevalence, silent progression, and significant impact on patients’ quality of life. Throughout this literature review, it was possible to demonstrate that these two chronic conditions constitute the main etiological factors for the development and worsening of renal dysfunction, being responsible for a large proportion of cases that progress to advanced kidney failure and require renal replacement therapies.
Zitieren
APA
Neta, A. D. C., Maia, D. L. C., Martins, E. A. M., Silva, Í. R. A., Lima, R. E. D., & Tourinho, L. D. O. S. (2026). Doença renal crônica secundária ao diabetes e hipertensão: uma breve revisão de literatura. Revista ft, 30(158), 01-18. https://doi.org/10.69849/6s1ekf63
Vancouver
Neta ADC, Maia DLC, Martins EAM, Silva ÍRA, Lima RED, Tourinho LDOS. Doença renal crônica secundária ao diabetes e hipertensão: uma breve revisão de literatura. Revista ft. 2026;30(158):01-18. doi:10.69849/6s1ekf63
BibTeX
@article{Neta2026,
author = {Neta, Ana Damiani Cabrini and Maia, Daniel Levy Calmont and Martins, Emily Araujo Mendes and Silva, Ítala Renata Alves and Lima, Ruan Escobar de and Tourinho, Luciano de Oliveira Souza},
title = {Doença renal crônica secundária ao diabetes e hipertensão: uma breve revisão de literatura},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {158},
pages = {01--18},
doi = {10.69849/6s1ekf63}
}
EUVIMED